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ABSTRACT
Familial expansile osteolysis and related disorders are caused by heterozygous tandem duplication mutations in the signal peptide
region of the gene encoding receptor activator of NF-kB (RANK), a receptor critical for osteoclast formation and function. Previous studies
have shown that overexpression of these mutant proteins causes constitutive activation of NF-kB signaling in vitro, and it has been
assumed that this accounts for the focal osteolytic lesions that are seen in vivo. We show here that constitutive activation of NF-kB
occurred in HEK293 cells overexpressing wild-type or mutant RANK but not in stably transfected cell lines expressing low levels of each
RANK gene. Importantly, only cells expressing wild-type RANK demonstrated ligand-dependent activation of NF-kB. When over-
expressed, mutant RANK did not localize to the plasma membrane but localized to extensive areas of organized smooth endoplasmic
reticulum, whereas, as expected, wild-type RANK was detected at the plasma membrane and in the Golgi apparatus. This intracellular
accumulation of the mutant proteins is probably the result of lack of signal peptide cleavage because, using two in vitro translation
systems, we demonstrate that themutations in RANK prevent cleavage of the signal peptide. In conclusion, signal peptidemutations lead
to accumulation of RANK in the endoplasmic reticulum and prevent direct activation by RANK ligand. These results strongly suggest that
the increased osteoclast formation/activity caused by these mutations cannot be explained by studying the homozygous phenotype
alone but requires further detailed investigation of the heterozygous expression of the mutant RANK proteins. 2011 American Society
for Bone and Mineral Research.
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Introduction
Osteoclasts are the multinucleated giant cells responsible forbone resorption and are derived from circulating hemato-
poietic cells of the macrophage-monocyte lineage.(1) Differenti-
ation of these precursor cells into osteoclasts is critically
dependent on the cell surface receptor activator of NF-kB
(RANK), a member of the tumor necrosis factor receptor
superfamily (encoded by TNFRSF11A).(2,3) Interaction of this 66-
kDa integral membrane protein with RANK ligand (RANKL),
expressed on stromal cells, osteoblasts, and activated T cells,
causes trimerization of the receptor and initiates a signaling
cascade that results in the activation of NF-kB and other
transcription factors, leading to osteoclastogenesis.(4–7)
Mutations in RANK have been identified as the cause of
familial expansile osteolysis (FEO), early-onset Paget disease of
bone (ePDB), and expansile skeletal hyperphosphatasia (ESH),
which are related disorders of bonemetabolism characterized by
focal areas of increased bone turnover together with a
generalized increase in bone remodeling.(8) Affected areas show
an increase in osteoclast number, multinuclearity, and activity,
which leads to the notion that these diseases are driven by
osteoclast overactivity, as is classic late-onset Paget disease of
bone.(9) Heterozygous tandem duplication mutations in the
signal peptide region of the RANK gene in patients with FEO
(84dup18), ePDB (75dup27), or ESH (84dup15) result in
extensions of 6, 9, or 5 amino acids, respectively, to the signal
peptide region of the RANK protein.(10,11) The duplication in
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ePDB is only associated with early-onset familial Paget disease
rather than the classic late-onset form of the disease.(12)
However, the exact molecular mechanism by which these
alterations in the RANK signal peptide lead to the characteristic
feature of osteoclast activation and enhanced bone turnover is
unknown. Similar to other membrane proteins, overexpression
of RANK in vitro causes constitutive activation of NF-kB.(13,14)
Overexpression of FEO-RANK and PDB-RANK in EBNA-293 cells
caused greater constitutive activation of NF-kB than wild-type
RANK (WT-RANK) when normalized to the level of RANK
protein.(10) This suggested that ligand-independent activation
of NF-kB could be a factor leading to the hyperactivated
osteoclasts observed in vivo, although the mechanism underly-
ing such activation was not examined. Therefore, the aim of this
study was to clarify how the signal peptide tandem duplication
mutations in RANK affect posttranslational processing and
subcellular localization of RANK protein and the downstream
activation of NF-kB.
Materials and Methods
Plasmids
pTREshuttle vector (BD Biosciences, Oxford, UK) has a minimal
CMV promoter with a tetracycline response element. Transcrip-
tion only occurs when the tetracycline-responsive transactivator
expressed by the Tet-Off-HEK293 cell line binds the Tet-
responsive element. pcDNA5-FRT vector has a CMV promoter
and contains a Flp-recombinase transferase (FRT) site for
integration of genes of interest into the genome of Flp-In-
293 cells (Invitrogen, Paisley, UK). pOG44 encodes the Flp
recombinase under the control of a CMV promoter. PDB-RANK (in
pBluescript SKII) was a kind gift from Immunex Corporation
(Amgen Inc, Thousand Oaks, CA, USA). All other materials were
purchased from Sigma (Poole, UK) unless otherwise stated.
Construction of pTREshuttle-RANK-FLAG vectors
A FLAG tag (GAC TAC AAG GAC GAC GAC GAC AAG) was inserted
directly upstream of the PDBRANK stop codon by site-directed
mutagenesis (SDM; Quik-Change SDM Kit; Stratagene, Amster-
dam, The Netherlands). WT-RANK-FLAG, FEO-RANK-FLAG, and
ESH-RANK-FLAG then were produced by polymerase chain
reaction (PCR)–based cloning from genomic wild-type human
DNA into the SalI/PstI sites (WT-RANK-FLAG) or by SDM (FEO-
RANK-FLAG and ESH-RANK-FLAG). These then were ligated into
the ApaI/NotI sites of the pTREshuttle vector (BD Biosciences)
using T4 DNA ligase (Roche Diagnostics, Ltd., Lewes, UK).
Construction of recombinant adenoviruses
Recombinant adenoviruses containing WT-RANK-FLAG, FEO-
RANK-FLAG, and PDB-RANK-FLAG were generated by ligation
using the Adeno-X-TetOff expression system (Takara Clontech,
Mountain View, CA, USA) following the manufacturer’s instruc-
tions. Briefly, the RANK cDNAs were excised from pTREshuttle
using PI-SceI and I-Ceu-I restriction enzymes and ligated into
linearized adenoviral DNA. The adenoviral DNA, containing the
RANK cDNA, was purified using a large-construct DNA purifica-
tion kit (Qiagen, Crawley, UK). Following PacI digestion to
linearize the adenoviral DNA, recombinant adenoviruses then
were produced by transfecting DNA into HEK293 cells by calcium
phosphate precipitation. After 4 to 7 days, the adenovirus was
harvested from the cells by rapidly freeze-thawing the cells.
Primary amplification adenoviral stocks were prepared by
amplification in HEK 293 cells cultured in 175-cm2 tissue culture
flasks, and these stocks were titered by endpoint dilution assay.
Typical titers were greater than 1 109 pfu/mL.
Construction of pcDNA-RANK-FLAG-FRT vectors and
generation of stable cell lines
The WT-RANK-FLAG, FEO-RANK-FLAG, PDB-RANK-FLAG, and
ESH-RANK-FLAG were ligated into the BamH I/Not I sites in
pcDNA5-FRT vector using T4 DNA ligase. The Flp-In system
(Invitrogen) was used to generate cell lines (Flp-WT, Flp-FEO, Flp-
PDB, and Flp-ESH) incorporating a single copy of each of the
RANK-FLAG cDNAs. Flp-In-293 cells (that stably express a FRT
site) were cultured in Dulbecco’s modified Eagle medium
(DMEM) containing 4500mg/mL of glucose and supplemented
with 10% (v/v) fetal calf serum (FCS), 2mM L-glutamine, 100U/
mL of penicillin, 100mg/mL of streptomycin, 100mg/mL of
zeocin. Flp-In-293 cells in 10-cm2 tissue culture plates were
transfected with 1mg of pcDNA5-RANK-FLAG plasmid together
with 9mg of pOG44 plasmid by Fugene 6 (Roche Diagnostics,
Ltd.) transfection. Stably transfected cells were selected in
medium containing 100mg/ml of hygromycin, and clones were
selected that were hygromycin-resistant, zeocin-sensitive, and
LacZ. Genomic DNA and RNA were isolated from each clone,
and the presence and expression of RANK-FLAG genes were
confirmed by Big Dye sequencing from PCR products amplified
using primers across exons 1 to 3 to amplify the region
containing the duplication mutations (fwd: 5’-gga tcc aga cat gat
aag gg-3’, which was anchored within the region of the
pcDNA5FRT expression vector immediately upstream of the
transcription start to ensure amplification of the exogenous
RANK genes; and rev: 5’-atc caa gta ttc atc cgg gcc c-3’, within
exon 3 of the RANK gene), and primers that specifically amplified
the FLAG region of the inserted RANK genes (fwd: 5’-aga aga agc
cag cag gac gga-3’; and rev: 5’-gct cac ttg tcg tcg tcg tcc-3’,
anchored within the FLAG tag). Expression of endogenous RANK
within the parental Flp-In-293 cell line was confirmed by RT-PCR
using one set of primers to amplify a region across exons 5 to 7 of
RANK (fwd: 5’-tgc agc tca aca agg aca cag-3’; and rev: 5’-gct gtg
agt gct ttc cct ttt-3’) and another set to amplify a region within
exon 9 (fwd: 5’-ttc acg ggg aca cag agc aca-3’; and rev: 5’-cct ccg
tcc tgc tgg ctt cttc-3’). Finally, to compare the relative level of
expression of RANK in the stable cell lines compared with
293 cells that had been transfected with the pcDNA5FRT-RANK
expression constructs, quantitative RT-PCR was performed on a
LightCycler 480 (Roche Applied Science, Basel, Switzerland)
using Universal Probes Mastermix (Applied Biosystems, Foster
City, CA, USA), gene-specific primers (fwd: 5’-gaa cat cat ggg aca
gag aaa-3’; and rev: 5’-ggc aag taa aca tgg ggt tc-3’) and Universal
Probe Number 53 (Applied Biosystems). GAPDH was used as the
housekeeping gene and was amplified simultaneously in parallel
samples using the GAPDH assay mix (human) (Applied
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Biosystems). RANK expression was normalized to GAPDH, and
expression relative to that in untransfected cells was calculated.
Cell culture and transfections
Tet-Off 293 cells (BD Biosciences) were cultured, as advised by
the supplier, on collagen-I-coated tissue culture vessels (Sigma,
Poole, UK) in a-modified minimum essential medium (a-MEM)
containing 1mMglutamine, 100 U/mL of penicillin, 100mg/mL of
streptomycin, 10mg/mL og G418, and 10% (v/v) Tet-approved
fetal bovine serum (FBS; BD Biosciences). 293 cells [European Cell
and Culture Collection (ECACC)] were cultured in a-MEM
containing 1mM glutamine, 100U/mL of penicillin, 100mg/mL
of streptomycin, and 10% (v/v) FCS.
Transfections were carried out using Fugene-6 (Roche
Diagnostics, Ltd.) approximately 18 hours after seeding. For
Western blot analysis, 293 cells were seeded into 12-well plates
at 4 105 cells/well, transfected with 0.25, 0.5, and 1mg of
pcDNA5-RANK-FLAG plasmids or pcDNA5FRT (empty vector) and
cultured for 24 hours. For immunostaining, 293 cells were
cultured on glass coverslips in 24-well plates at 1 105 cells
per well, transfected with 0.5mg of pcDNA5-RANK-FLAG or
pcDNA5FRT (empty vector), and cultured for 48 hours. For
reporter assays to assess the effect of overexpression of the
RANK constructs on NF-kB activation, Tet-Off 293 cells or Flp-
RANK cell lines were seeded into 48-well plates at 1 105 cells/
well and transfected as described for each experiment.
Generation of human osteoclast-like cells and
transduction with RANK recombinant adenoviruses
Ethical permission for the culture of cells derived from the blood
of healthy volunteers was obtained from the North of Scotland
Research Ethics Committee. Peripheral blood mononuclear cells
were isolated from human peripheral blood by Lymphoprep
density centrifugation and cultured for 7 days in the presence of
20 ng/mL of recombinant human macrophage colony-stimulat-
ing factor (rhM-CSF; R&D Systems, Minneapolis, MN, USA) to give
cultures of enriched M-CSF-dependent monocytes. Cells were
removed from the flasks by trypsinization for 30minutes in
trypsin/EDTA and scraped gently into a-MEM supplemented
with 10% (v/v) FCS, 1mM L-glutamine, 100 U/mL of penicillin,
100mg/mL of streptomycin, and 20 ng/mL of rhM-CSF. They then
were seeded onto 9-mm coverslips (preincubated in FCS for
30minutes) in 48-well plates at a density of 3 104 cells/well or
onto Whatman 0.45-mm nitrocellulose filter paper in 96-well
plates and cultured in 100 ng/mL of rhRANKL (Pepro-Tech, Rocky
Hill, NJ, USA) and 20 ng/mL of rhM-CSF for about 5 days until the
appearance of large, multinucleated osteoclast-like cells in the
48-well plates. The medium was removed, and the cells were
incubated for 3 hours in 200 pfu/cell Tet regulatory adenovirus
together with 200 pfu/cell WT-RANK-FLAG, FEO-RANK-FLAG, or
PDB-RANK-FLAG adenoviruses in 100mL (48-well plates) or 50mL
(96-well plates) serum-free a-MEM supplemented with 1mM L-
glutamine, 100U/mL of penicillin, 100mg/mL of streptomycin,
20 ng/mL of rhM-CSF, and 100 ng/mL of rhRANKL. The plates
were incubated for 3 hours and then supplemented with 100mL
(48-well plates) or 50mL (96-well plates) of a-MEM supplemen-
ted with 20% Tet-approved FCS, 1mM L-glutamine, 100U/mL of
penicillin, 100mg/mL of streptomycin, 20 ng/mL of rhM-CSF, and
100 ng/mL of rhRANKL. The cells were incubated for 48 hours
and then fixed for immunostaining and confocal microscopy or
for TEM analysis.
Detection of WT-, FEO-, PDB-, or ESH- RANK-FLAG
expression by Western blot analysis
Twenty-four hours after transfection, cells were prepared for
Western blot analysis. The cells were washed in ice-cold PBS and
lysed in 100mL of radioimmunoprecipitation assay (RIPA) buffer
[1% (vol/vol) NP-40, 0.5% (wt/vol) sodium deoxycholate, 0.1%
(wt/vol) SDS in PBS) containing 1% protease inhibitor cocktail
(Sigma). The lysates were vortexed and incubated on ice for
15minutes. Insoluble material was removed by centrifugation
(13,000 g, 15minutes). After protein determination (Bicincho-
ninic Acid Assay; Sigma), 50mg of protein from each lysate were
electrophoresed under reducing conditions on a 12% polyacryl-
amide-SDS resolving gel. The proteins were blotted onto
polyvinylidenedifluoride membrane, which was incubated with
0.5mg/mL of mouse monoclonal anti-RANK antibody (IMG-128;
Imgenex Corporation, San Diego, CA, USA), 5mg/mL of rabbit
anti-FLAG antibody (Sigma) followed by infrared-labeled anti-
mouse-800 (Licor Biosciences, Cambridge, UK) and anti-rabbit-
680 (Invitrogen) secondary antibodies. The infrared signals were
detected using the Odyssey imaging system (Licor Biosciences).
Detection of WT-, FEO-, PDB-, or ESH-RANK-FLAG
expression by immunostaining
Twenty-four or 48 hours after transfection/transduction, the cells
were fixed for 20 minutes in CytoFix-CytoPerm (BD Biosciences)
at 48C and then washed in CytoFix-CytoPerm wash solution,
blocked in 10% (vol/vol) FBS (in PBS), and incubated in 20mg/mL
of mouse monoclonal anti-FLAG antibody (Sigma), followed by
20mg/mL of Alexafluor antimouse-IgG 594 (Molecular Probes,
Leiden, The Netherlands). Cells were also stained with a Golgi
marker (10mg/mL of wheat germ aggluttinin-633 (WGA-633);
Invitrogen), the nuclei were counterstained with 10mM Sytox
Green (Invitrogen), and the coverslips were mounted in
Vectashield (Vector Laboratories, Peterborough, UK). The cells
were visualized on an LSM510 Meta confocal microscope (Carl
Zeiss, Ltd., Welwyn Garden City, UK), and images were captured
using LSM image software (Carl Zeiss, Ltd.).
Detection of RANK-FLAG expression by immunoEM
293 cells in 6-well plates were transiently transfected with 1mg
WT-, FEO-, or PDB-RANK-FLAG using Fugene-6. The cells were
incubated for 24 hours and then were fixed, embedded, and
sectioned for transmission electron microscopy (TEM). The cells
were pelleted by centrifugation and then fixed for 1 hour in 4%
paraformaldehydeþ 0.1% glutaraldehyde in 0.1M sodium
cacodylate buffer. Cell pellets then were cut in two. One-half
was placed into 2% glutaraldehyde in 0.1M sodium cacodylate
buffer for processing to Epon resin for conventional TEM. The
other half was placed in fresh 4% paraformaldehyde and
processed to Lowicryl HM20 resin using a progressive lowering-
of-temperature protocol in a Leica AFS2. RANK-FLAG proteins
were then detected on ultrathin sections using 4mg/mL of rabbit
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anti-FLAG antibody followed by 1:20 dilution of 10 nm of Protein
A Gold (Aurion, Wageningen, The Netherlands). All sections
(Epon and Lowicryl) were counterstained with uranylacetate and
lead citrate and examined in a Philips CM10 microscope and
images captured using a 600-W camera (Gatan, Abingdon, UK).
Reporter assays
To determine the effect of the mutations on constitutive NF-kB
activation, Tet-Off 293 cells were transfected with 1, 5, 10, and
30 ng of pTRERANK-FLAG plasmids or 30 ng of pTREshuttle
together with 60 ng of pNF-kB reporter plasmid (8 replicate wells
per transfection). To determine the effect of the mutations on
constitutive and RANKL-dependent NF-kB activation, Tet-Off
293 cells were transfected with 5 ng of pTRERANK-FLAG plasmids
or 5 ng of pTREshuttle together with 60 ng of pNF-kB reporter
plasmid (Takara Clontech) and 10 ng of pshuttle LacZ (8 replicate
wells per transfection). After 24 hours, 4 wells of each transfected
cell culture were stimulated with 100 ng/mL of RANKL (Pepro-
Tech) for a further 24 hours. To determine the effect of the
mutations on RANKL-dependent activation of NF-kB in cells that
stably express low levels of the RANK proteins, Flp-RANK cells
were transfected with 150 ng of pNF-kB reporter plasmid and
150 ng of pTKRenilla (8 replicate wells per transfection). After
24 hours, 4 wells of each transfected cell culture were stimulated
with 100 ng/mL of RANKL (PeproTech) for a further 24 hours.
In all cases, after treatment, the cells were washed in PBS and
lysed in 40mL of passive lysis buffer (Promega UK, Ltd.,
Southampton, UK). The samples were analyzed for firefly and
either Renilla luciferase activity using the Dual Luciferase Assay
Kit (Promega) and theWallac 1420 Victor2 multilabel plate reader
(Perkin Elmer, Cambridge, UK), or b-galactosidase expression
was measured using the b-galactosidase assay (Promega) by
absorbance at 405 nm on a Bio-Tek FL600 plate reader (Bio-Tek
Instruments, Inc., Winooski, VT, USA).
In vitro translation assays
WT-, FEO-, PDB-, and ESH-RANK-FLAG were cloned into the ApaI/
NotI sites in a modified SP64T vector (Krieg and Melton, 1984)
that allows transcription of mRNA that is flanked by the 5’ and 3’
untranslated regions of b-globin RNA to improve stability of the
mRNA in the translation systems. The RANK-SP64T vectors
(20mg) were linearized with Xho1, and cRNA was prepared as
described previously.(15) To determine whether signal peptide
cleavage occurs in each protein, the mass of proteins that had
been translated in the XEE (in the presence of NYT) was
compared with that translated in the RRL. The XEE translation
was carried out as previously described(15) using 1mL of H2O or
RNA encoding either WT-, FEO-, PDB-, or ESH-RANK-FLAG in the
presence or absence of 1.2mM tripeptide (acetyl)-Asn-Tyr-Thr-
(amide) (NYT) to inhibit glycosylation. RRL translations were
carried out following manufacturer’s instructions (Promega)
using 1mL of H2O or WT-, FEO-, PDB-, or ESH-RANK RNA and
allowed to proceed for 1 hour. All translations were analyzed on
an 8% SDS-polyacrylamide (Tris-glycine buffer) gel. Following
fluorography, the gel was exposed to film overnight at 808C.
To determine the orientation of each protein in the in vitro
membranes, a protease protection assay was carried out (in a XEE
translation), as described previously,(15) using 1mL of RNA
encoding either WT-, FEO-, PDB-, or ESH-RANK-FLAG. Within an
XEE translation, proteins are inserted into the membrane vesicles
so that the protein domains that would be expected to be
intracellular are on the outside face of the vesicles, and the
extracellular domain of the protein is within the vesicle (as
represented in the schematic diagram in Fig. 7B). This means that
when the vesicles that carry the proteins are exposed to
proteinase K, the intracellular domain of the protein will be
degraded, and the extracellular domain will be protected and
still will be intact when the products are analyzed by PAGE and
fluorography. Proteinase K activity was inhibited by addition of
PMSF before the samples were analyzed on a 12.5% SDS-
polyacrylamide (Tris-glycine buffer) gel. Following fluorography,
the gel was exposed to film overnight at 808C.
Statistical analysis
Statistical significance was calculated using a one-way ANOVA
with Tukey post hoc test.
Results
FEO-RANK, PDB-RANK, and ESH-RANK proteins are of
higher molecular mass and are expressed at lower levels
than WT-RANK
To confirm expression of WT-, FEO-, PDB-, and ESH-RANK, HEK
293 cells were transfected with RANK-FLAG expression plasmids,
and the RANK proteins were detected 48 hours later by Western
blot analysis using anti-RANKmonoclonal (mouse) and anti-FLAG
polyclonal (rabbit) antibodies. WT-RANK was identified as a band
of approximately 70 kDa (Fig. 1), whereas the bands correspond-
ing to FEO-, PDB-, and ESH-RANK were slightly greater. The level
of FEO-RANK, ESH-RANK, and PDB-RANK protein in lysates of
transiently transfected cells was lower than that of WTRANK
when normalized to the level of b-actin. To determine whether
the apparently lower levels of mutant RANK versus WTRANK
were as a result of increased proteasomal degradation, cells were
treated with 1mM MG132 for the final 24 hours of culture. This
did not increase the relative levels of any of the proteins.
Expression levels of RANK in Flp-WT, Flp-FEO, Flp-PDB,
and Flp-ESH cell lines are much lower than in cells that
have been transiently transfected with RANK constructs
Integration of the wild-type and mutant RANK-FLAG constructs
into the FRT site within the Flp-In-293 cell line was confirmed by
hygromycin resistance, zeocin sensitivity, and loss of b-
galactosidase expression (data not shown). Sequencing data
of regions within exons 1 to 3 and across the FLAG tag (Fig. 2A)
confirm that within each cell line the relevant tandem
duplication mutation and FLAG tag is present (Fig. 2B, C). Using
a pair of primers that amplified exons 3 to 7, RANK could be
detected in the genomic DNA from Flp-WT, Flp-FEO, Flp-PDB,
and Flp-ESH but not in the parental Flp-In cell line, whereas
within the cDNA synthesized from the same cell lines, RANK was
detected in all cases, as expected (Fig. 2D). In all cell lines,
including Flp-In-293 cells, a product was detected using primers
that amplified a region within exon 9 (Fig. 2E). Quantitative
SIGNAL PEPTIDE MUTATIONS IN RANK Journal of Bone and Mineral Research 1929
polymerase chain reaction (qPCR) using RANK-specific primers
together with a UPL probe confirmed that in transient
overexpression experiments, when normalized to GAPDH, levels
of RANK expression were between 6500 and 50,000 times greater
than levels of RANK expression in the untransfected cells,
whereas in the stable cell lines, relative RANK expression levels
were between 1.1 and 23 times greater than in the parental Flp-
In-293 cell line (Fig. 2F). In addition, the expression levels of RANK
in 293 cells was very low compared with human peripheral blood
mononuclear cells and human osteoclast-like cells, in which
expression levels were approximately 40 and 20 times more than
in 293 cells, respectively (Fig. 2G).
Overexpression of WT-RANK-FLAG, FEO-RANK-FLAG, PDB-
RANK-FLAG, and ESH-RANK-FLAG causes constitutive
activation of NF-kB, but only cells overexpressing
WTRANK show RANKL-dependent activation of NF-kB
Using a luciferase reporter assay to measure NF-kB activation,
overexpression of WT-RANK-FLAG, FEO-RANK-FLAG, PDB-RANK-
FLAG, and ESH-RANK-FLAG in TetOff293 cells caused constitutive
activation of NF-kB. This effect depended on the amount (1 to
30 ng) of RANK plasmid transfected into the cells (Fig. 3A). As
reported previously,(10) more constitutive activation of NF-kB
was detected in cells overexpressing FEO-RANK than WT-RANK,
but NF-kB activation in cells overexpressing PDB-RANK or ESH-
RANK was not different from that seen in WT-RANK-transfected
cells. To study the effect of the RANK mutations on RANKL-
induced signaling, TetOff293 cells were transfected with just 5 ng
of WT-RANK-FLAG, FEO-RANK-FLAG, PDB-RANK-FLAG, or pESH-
RANK-FLAG together with 150 ng of pNF-kB-luc and 150 ng of
placZ plasmid. This amount of RANK plasmid was selected
because it produced a relatively low but significant (p< .001,
three independent experiments) level of constitutive activation
of NF-kB in the experiments described earlier. After 24 hours, the
cells were treated with 100 ng/mL of rhRANKL or control medium
for a further 24 hours. Only the cells transfected with WT-RANK
showed a significant increase (p< .001, three independent
experiments) in luciferase activity in response to RANKL
treatment, demonstrating RANKL-dependent activation of NF-
kB via WT-RANK but not via mutant RANK proteins (Fig. 3B).
Flp-WT cells show RANKL-dependent activation of NF-kB
To further distinguish between activation of NF-kB owing to
overexpression of RANK proteins and possible activation of NF-
Fig. 1. WT-RANK-FLAG is of lower molecular mass and is more abundant than mutant RANK-FLAG protein, which is not as a result of increased
proteasomal degradation of the mutant proteins. Infrared (Licor) detection of (A) RANK (800 nm) and (B) FLAG and actin expression (680 nm) on the same
Western blot of 293 cells that had been mock transfected 48 hours previously (CTL) or transfected with 0.5mg of pcDNA5FRT (EV), WT-RANK-FLAG, FEO-
RANK-FLAG, PDB-RANK-FLAG, or ESH-RANK-FLAG in the presence or absence of 1mM MG132 for the final 24 hours of culture. Data are representative of
three independent experiments.
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Fig. 2. Confirmation of RANK expression in Flp-In cell lines by RTPCR, qPCR, and sequencing using construct-specific primers (A). The region around the
tandem duplications in RANK was amplified by PCR 1 from genomic DNA from all Flp-In cell lines (B, left panel), and the products were sequenced and
aligned to a consensus WT-RANK sequence to confirm that each cell line contained the expected duplication (B, right panel: FEO 18 bp, PDB 27 bp, ESH 15
bp). The region around the FLAG tag was amplified by PCR 2 from genomic DNA from all Flp-In cell lines (C, left panel, top) with primers to amplify b-actin as
housekeeping gene (C, left panel, bottom). The products were sequenced and aligned to a consensus RANK-FLAG sequence to confirm the presence of the
C-terminal end of the RANK-FLAG constructs within each cell line (C, right panel). (D) PCR 3 was performed on genomic (g) and cDNA synthesized from RNA
(c) extracted from all Flp-In cell lines, and PCR 4 was performed on genomic DNA (E). All PCR products were analyzed by ethidium bromide agarose gel
electrophoresis with HincII DNA size markers, and the expected band sizes for each PCR reaction are shown in A. Data from QPCR (UPL probe 53) for ( F)
293 cells that had been transiently transfected with RANK constructs or Flp-In cell lines stably expressing the RANK-FLAG genes and (G) 293, human
peripheral blood mononuclear cells, and human osteoclast-like cells. The data represent the DDCP values normalized to GAPDH relative to expression
levels in untransfected (UTX) cells. All qPCR data are representative of two independent experiments (three replicates per experiment). Note the log scale
on the y axis in F.
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kB under more physiologic conditions of lower expression of
RANK, Flp-In-293 cells and Flp-WT, Flp-FEO, Flp-PDB, and Flp-ESH
cells were cultured in 48-well plates and transfected with 150 ng
of pNF-kB-luc and 150 ng of pTKrenilla plasmids. After 24 hours,
the cells were cultured with or without 100 ng/mL of rhRANKL for
a further 24 hours. NF-kB activation was assessed using a
luciferase assay. In the absence of exogenous RANKL, no
constitutive activation of NF-kB was detected in any of the RANK-
expressing cell lines compared with the untransfected Flp-In-293
cell line (Fig. 3C). After RANKL treatment, NF-kB activation in Flp-
FEO, Flp-PDB, and Flp-ESH cells was not increased significantly,
whereas a significant increase was seen in Flp-WT cells in
response to RANKL (p< .05, three independent experiments).
The same pattern of NF-kB activation also was observed in
experiments in which NF-kB signaling was measured 30 and
60minutes after stimulation with RANKL by using an activated
p65 TRANSAM assay (Active Motif, Rixensart, Belgium) (data not
shown).
The subcellular localization of FEO-RANK-FLAG, PDB-
RANK-FLAG, and ESH-RANK-FLAG is distinct from that of
WT-RANK-FLAG
To study the subcellular localization of mutant RANK, 293 cells
were transiently transfected with WT-, FEO-, PDB-, and ESH-
RANK-FLAG, immunostained for FLAG, and analyzed by confocal
microscopy 24 hours after transfection. WT-RANK-FLAG was
detected at the cell surface and in the Golgi apparatus (Fig. 4A)
because FLAG colocalized with WGA-633, a Golgi marker. FEO-
RANK-FLAG and PDB-RANK-FLAG were not detected at the cell
surface and appeared in a tight ring around the nucleus and in
membrane structures close to the nucleus that did not stain with
WGA-633 (Fig. 4B, C). ESH-RANK-FLAG was detected in vesicular
structures throughout the cytosol (Fig. 4D) and was not
associated with the Golgi.
When human osteoclast-like cells were transduced with
adenoviral-RANK-FLAG, immunostained for FLAG, and examined
by confocal microscopy, WT-RANK-FLAG was detected through-
out the cytosol and at the plasma membrane (Fig. 5A). By
contrast, FEO-RANK-FLAG was detected in a region between the
nuclei and the plasma membrane (Fig. 5B) and appeared to be
associated with small ringlike structures that formed a larger
structure surrounding the nuclei (Fig. 5B, inset), reminiscent of
the circular structures that FEO-RANK-FLAG localized to in
293 cells. The pattern of localization of PDB-RANK-FLAG (Fig. 5C)
was not as distinct as that of FEO-RANK-FLAG and appeared
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Fig. 3. Overexpression of wild-type or mutant RANK proteins in Tet-Off
293 cells constitutively activates NF-kB, but expression of low levels of
any of the RANK genes does not. In both cases, only cells expressing WT-
RANK show NF-kB activation in response to RANKL. (A) NF-kB activation
was assessed by luciferase reporter assay 48 hours after transfection of
Tet-Off-293 cells with 1 ng (white), 5 ng (vertical lines), 10 ng (diagonal
lines), or 30 ng (black) of RANK constructs together with 150 ng NF-kB–
luciferase reporter. Results (mean SD, at least four replicates per
treatment per experiment) are expressed as relative luminescent activity
(arbitrary units). The data are representative of three independent
experiments. (B) NF-kB activation was assessed by luciferase reporter
assay 48 hours after transfection of 293 cells with 5 ng of pTRE-RANK
constructs together with 150 ng of NF-kB–luciferase reporter and 150 ng
of placZ in the absence (white bars) or presence (gray bars) of 100 ng/mL
of rhRANKL for the final 24 hours of culture. Results (mean SD, at least
four replicates per treatment per experiment) are expressed as luciferase/
b-galactosidase activity. Significantly different from unstimulated cells,
p< .001 (one-way ANOVA). The data are representative of three inde-
pendent experiments. (C) NF-kB activation was assessed by luciferase
reporter assay in Flp-In, WT-Flp, FEO-Flp, PDB-Flp, and ESH-Flp cells
48 hours after transfection with 150 ng of NF-kB–luciferase reporter
and 150 ng of pTK-renilla luciferase in the absence (white bars) or
presence (gray bars) of 100 ng/mL of rhRANKL for the final 24 hours of
culture. Results (mean SD, at least four replicates per treatment per
experiment) are expressed as percentage Firefly/Renilla luciferase activi-
ty. Significantly different from unstimulated cells, p< .05 (one-way
ANOVA). The data are representative of three independent experiments.
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intermediate between that of WT-RANK-FLAG and FEO-RANK-
FLAG.
Localization of WTRANK and mutant RANK proteins by
immunoEM
To investigate the exact subcellular localization of RANK at the
ultrastructural level, HEK 293 cells were transiently transfected
with RANK expression plasmids. After 24 hours, the cells fixed and
processed for conventional TEM or were immunostained using
rabbit anti-FLAG primary antibody and 10 nm of gold-labeled
secondary antibody and analyzed by TEM. The pattern of
staining was very similar to that observed by fluorescence
immunostaining. Extended Golgi apparatus could be observed in
approximately 20% of osmium-fixed WT-transfected cells
analyzed by routine TEM (Fig. 6A, ii), whereas this was not
detected in any empty vector–transfected cells (Fig. 6A, i). In
agreement, gold particles were observed in a tight ring around
the nucleus in the rough endoplasmic reticulum and in the Golgi
apparatus (Fig. 6B, i) of WT-transfected cells. When osmium-fixed
FEO- and PDB-RANK-transfected cells were analyzed by routine
TEM, numerous concentric circular structures were observed
within the cytosol of about 26% of the cells examined,
continuous with the endoplasmic reticulum and similar to
organized smooth endoplasmic reticulum (OSER(16); Fig. 6A,
iii–vi). When this was compared with the FLAG-stained cells, gold
Fig. 4. WT-RANK is present in the ER, Golgi, and plasma membrane, but RANK mutants appear to accumulate intracellularly and are not detected
predominantly in the Golgi or at the plasma membrane. Thus 293 cells transfected with (A) WT-RANK-FLAG, (B) FEO-RANK-FLAG, (C) PDB-RANK-FLAG, and
(D) ESH-RANK-FLAG were immunostained for FLAG (green, i) and stained for Golgi apparatus (wheat germ agglutinin-633; red, iii), and DNA (Sytox green:
blue, iii) and analyzed by laser scanning confocal microscopy. xy sections of representative cells are presented. Panel iv in each case represents the merged
images. Scale bar¼ 10mm.
SIGNAL PEPTIDE MUTATIONS IN RANK Journal of Bone and Mineral Research 1933
particles could be detected only on these membrane structures
(Fig. 6B, ii and iii). No OSER was observed inWT-RANK-transfected
or cells transfected with empty vector (Fig. 6A, i and ii).
Human osteoclast-like cells grown on nitrocellulose filters and
transduced with adeno-WT-RANK-FLAG or adeno-FEO-RANK-
FLAG were examined by TEM. In FEO-RANK-FLAG-transduced
cells, extensive OSER was observed, consistent with the circular
structures observed by confocal microscopy (Fig. 7B). These
structures were not observed in WT-RANK-FLAG-transduced
osteoclasts (Fig. 7A) or in untransduced osteoclasts (not shown).
The signal peptide is not cleaved from FEORANK,
PDBRANK, or ESHRANK proteins
To investigate signal peptide cleavage, we compared the
molecular mass of proteins synthesised in the Xenopus egg
extract (XEE) system with the mass of proteins synthesized in the
rabbit reticulocyte system. The XEE system is a homologous
coupled translation/translocation system that allows membrane
insertion (including signal peptide cleavage) and posttransla-
tional modifications (including glycosylation).(15) By contrast, the
rabbit reticulocyte lysate (RRL) does not contain any membranes,
and therefore translated products are not posttranslationally
modified.(17) By using the glycolysation inhibitor NYT in the XEE
system, we were able to directly compare the mass of proteins
translated in the two systems in the absence of posttranslational
glycosylation. Whereas WT-RANK-FLAG was of lower mass when
synthesized in the XEE system compared with the RRL system,
FEO-, PDB- and ESH-RANK-FLAG proteins were of the same mass
in both translation systems (Fig. 8A), indicating that the signal
peptide is not cleaved from the mutant proteins. This is so
despite the fact that the mutant proteins still can be glycosylated
(Fig. 8A), as demonstrated by a shift in protein mass in the
presence/absence of NYT in the XEE system. These data, together
with the evidence for lack of ligand-dependent signaling
downstream of FEO-, PDB-, and ESH-RANK, strongly suggest
that the signal peptide is not cleaved from the mutant proteins
and that this prevents plasma membrane localization of the
mutant proteins. Finally, despite the lack of signal peptide
cleavage, the mutant proteins still could be inserted into the
membrane and in the correct orientation in the XEE system, as
demonstrated by a protease protection assay showing the shift
in molecular mass from approximately 70 to 27 kDa. This
demonstrates that the extracellular domain of RANK was
protected from proteinase K digestion in all proteins (Fig. 8B).
Discussion
RANK is present as a transmembrane receptor at the plasma
membrane of osteoclasts and their precursors. Oligomerization,
via a cytoplasmic oligomerization motif, is an absolute
requirement for osteoclast formation but can occur in the
absence of RANKL.(18) Signaling from the RANK receptor, via NF-
kB, NFATc1, and AP-1, depends on several cytoplasmic domains
of the RANK protein(19,20) that are important for its interaction
with downstream mediators, including TRAF6.
FEO, ePDB, and ESH are closely related skeletal disor-
ders(12,21,22) that are sometimes characterized by localized
Fig. 5. Mutant RANK accumulates intracellularly in human osteoclasts.
Human osteoclasts transduced with adenoviral (A) WT-RANK-FLAG, (B)
FEO-RANK-FLAG (including inset magnification of highlighted region),
and (C) PDB-RANK-FLAG were immunostained for FLAG (red) and stained
for DNA (Sytox green: green) and analyzed by laser scanning confocal
microscopy. Images presented are xy sections (scale bar shown on each
image) of representative cells.
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osteolytic lesions as a result of hyperactive osteoclasts on a
background of increased generalized bone turnover. The
disorders are caused by insertion mutations in the signal
peptide of RANK that cause amino acid duplications of 6 (FEO,
from residue 21), 9 (ePDB, from residue 18), and 5 (ESH, from
residue 21), respectively.(10,11) The exact mechanism by which
the RANK mutations affect downstream signaling pathways
remains unclear. To investigate the outcome of carriage of these
three RANKmutations on the processing and signaling via RANK,
we overexpressed the mutant proteins in cell lines and primary
human osteoclast-like cells.
In the initial study by Hughes and colleagues, it was suggested,
following overexpression studies in EBNA293 cells, that FEO-
RANK and PDB-RANK caused constitutive activation of NF-kB,
thereby leading to the characteristic overactive osteoclast
phenotype.(10) Although we also found that overexpression
of FEO-RANK and PDB-RANK, as well as ESH-RANK, results in
constitutive activation of NF-kB in 293 cells, we found that NF-kB
was not constitutively activated in a more physiologic model
(293 cells stably transfected with a single copy of the RANK
genes), suggesting that the constitutive activation of NF-kB seen
in overexpression models could be as a result of ER overload. The
latter effect is known to cause NF-kB activation when any
transmembrane protein is overexpressed.(23) Ligand-dependent
activation of NF-kB occurred only in cells expressing WT-RANK-
FLAG (either overexpression or physiologic expression), provid-
ing further evidence of lack of plasma membrane localization of
the mutant RANK proteins.
Alternatively, constitutive activation of NF-kB in the presence
of overexpressed RANK proteins could occur as a result of a
RANK-dependentmechanism. Since the transmembrane domain
of RANK is predicted to be at positions 201–222, it is expected
that the N-terminal extracellular domain (approximately 400
amino acids) should be protected from proteinase K treatment in
Fig. 6. Overexpression of FEO-RANK-FLAG or PDB-RANK-FLAG in 293 cells results in OSER formation. (A) TEM analysis at low (i–iii, v) or high (iv, vi)
magnification of 293 cells that had been (i) mock transfected show normal cellular ultrastructure, (ii) WT-RANK-FLAG transfected cells show extended Golgi
(EG); or (iii, iv) FEO-RANK-FLAG or (v, vi) PDB-RANK-FLAG transfected cells show organized smooth endoplasmic reticulum (OSER). Regions highlighted by
boxes in iii and v are shown at higher magnification in iv and vi. (B) ImmunoEM analysis of 293 cells that had been transfected with (i) WT-RANK-FLAG show
10-nm gold particles localized to the RER and extended Golgi (EG) or with (ii) FEO-RANK-FLAG or (iii) PDB-RANK-FLAG show particles localized to OSER.
Scale bars are shown on each image. N¼ nucleus.
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the protease protection assay that we employed (because it will
be within the lumen of the membrane vesicles containing the
newly translated/translocated protein). This was confirmed when
the [35S]methionine-labeled protein was reduced from approxi-
mately 600 amino acids to approximately 200 amino acids
following proteinase K digestion. Since WT-RANK-FLAG and the
three mutant RANK proteins were inserted in the expected
orientation within the membrane (ie, C-terminus in the cytosol),
this leaves the possibility that signaling proteins (such as TRAF6)
still may interact with the C-terminal domains of RANK, even if
the protein is trapped in the ER. However, although we have
observed that the wild-type and mutant RANK proteins can
interact with TRAF6 as measured by immunoprecipitation, when
cells overexpressing the RANK constructs were cotransfected
with a construct expressing a dominant-negative form of TRAF6,
there was no effect on the constitutive levels of NF-kB activation,
but ligand-dependent activation of NF-kB was at least partially
prevented (data not shown).
As an integral plasmamembrane protein, RANK is predicted to
be translated and translocated into the rough endoplasmic
reticulum (RER), where the signal peptide is removed by signal
peptidase [predicted by SignalP 3.0 to occur between amino acid
residues 27 (Ala) and 28 (Leu)] and where glycosylation can occur
on the two predicted N-terminal glycosylation motifs (Asn-X-Ser/
Thr). As expected, WT-RANK-FLAG was detected both within the
Golgi apparatus and at the plasma membrane of 293 cells and
transduced human osteoclasts by immunostaining. By contrast,
RANK proteins carrying the FEO, PDB, and ESH mutations were
not detected in the Golgi apparatus or at the plasma membrane,
but in transfected 293 cells and transduced osteoclasts, they
accumulated within multilamellar extensions of the ER reminis-
cent of OSER, a feature associated with the overexpression of ER-
resident transmembrane proteins.(16,24) This is relevant because,
as we demonstrate here, the insertionmutations in RANK prevent
cleavage of the signal peptide, making the protein effectively an
ER-resident protein. This is in agreement with Hughes and
Fig. 7. TEM analysis demonstrates that overexpression of FEO-RANK-FLAG in human osteoclasts results in OSER formation. Human osteoclasts that had
been transduced with (A) adeno-WT-RANK-FLAG show normal cellular ultrastructure. When cells were transduced with (B) adeno-FEO-RANK-FLAG, OSER
formation can be seen clearly. Scale bars are shown on each image. N¼nucleus; ER¼ endoplasmic reticulum; OSER¼ organized smooth endoplasmic
reticulum.
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colleagues, who predicted that the signal peptides within FEO-
RANK and PDB-RANK were not cleaved based on SignalP 3.0 data
and differences in molecular mass compared with WT-RANK.(10)
Accumulation of both FEO-RANK and PDB-RANK proteins caused
OSER formation—in FEO-RANK-transfected cells, the OSER
structures seemed to be continuous with the RER and
predominantly perinuclear, whereas PDB caused OSER formation
throughout the cytoplasm. All OSER formed was of a lamellar
type when compared with previous studies of other over-
expressed ER-resident proteins.(16) Formation of OSER was clearly
associated with overexpression of mutant RANK protein because
no OSER was detected in cells transfected with WTRANK or in
osteoclasts transduced with empty vector. Furthermore, FLAG
staining was almost exclusively localized to the OSER structures
in FEO-RANK- and PDB-RANK-transfected 293 cells analyzed by
immunoEM. In agreement with OSER formation being a feature
of protein overexpression, it was not detected in the stable cell
lines expressing just a single copy of WT-RANK, FEO-RANK, PDB-
RANK, or ESH-RANK (data not shown), and OSER has not been
described in human bone biopsies in FEO, PDB, or ESH patients.
Furthermore, OSER does not resemble the cytoplasmic inclusions
that have been observed in the osteoclasts of some FEO patients,
the exact origin of which is still a matter of debate between
laboratories that suggest they are evidence of previous exposure
to paramyoxiviridae and those which have been unable to detect
viral transcripts within any pagetic patient samples tested.(25)
Thus, although formation of OSER appears to be an artifact of
overexpression of the RANK mutants, this phenomenon clearly
demonstrates that the mutations cause localization of RANK in
the ER and prevent its targeting to the plasma membrane.
Taken together, these data provide convincing evidence that
the signal peptide mutations in the RANK gene result in
functional inactivation of the RANK signaling pathway because of
lack of translocation of the receptor to the plasma membrane.
These observations are supported by recent phenotypic
characterization of a transgenic knock-in mouse model
engineered to express Rank containing the PDB mutation.(26)
While homozygous mice had an osteopetrotic phenotype
consistent with complete absence of functional RANK protein,
heterozygotes showed severe osteolytic lesions and represent a
phenocopy of ePDB patients. While our studies show that
constitutive activation of NF-kB in cells is only a feature of cells
that overexpress either wild-type or mutant RANK proteins, we
do not exclude the possibility that in patient cells there may be
Fig. 8. The signal peptide is cleaved from WT-RANK-FLAG but not from FEO-RANK-FLAG, PDB-RANK-FLAG, or ESH-RANK-FLAG. (A) All proteins can be
glycosylated, as demonstrated when [35S]methionine-labeled XEE translation products the glysosylation inhibitor NYT were separated on an 8%
polyacrylamide gel. Signal peptide cleavage (two arrowheads) in WT-RANK-FLAG but not in the mutant proteins can be observed by comparing the size of
[35S]methionine-labeled XEE translation products in the presence of NYT with RRL translation products. (B) Membrane insertion and orientation of the
proteins were determined following proteinase K digestion of [35S]methionine-labeled XEE translation products from RANK RNAs that were separated on a
12.5% polyacrylamide gel. The 27-kDa product that remained in all cases following proteinase K treatment shows that the extracellular domain was
protected from digestion (illustrated by the schematic representation), and therefore, all the proteins are inserted in the correct orientation in the
membrane.
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increased RANK-dependent signaling as a result of interaction
between the wild-type protein and the mutant protein that may
affect the regulation of signaling downstream from the receptor.
Further studies on RANK signaling in heterozygous models of
wild-type and mutant RANK, including in vivo models, are clearly
required to fully understand how signal peptide mutations in
RANK cause osteoclast overactivity.
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